GLP-1 Weight Loss Blog

Research consistently shows telehealth weight loss programs produce outcomes comparable to in-person care — often with better adherence due to convenience.

Nausea is the most common side effect of semaglutide, but it's manageable. Here's why it happens and the most effective ways to reduce it.

Long-term GLP-1 weight loss is achievable — but it requires a thoughtful maintenance strategy. Here's what the research shows about sustained results.

Stopping semaglutide without a maintenance plan typically leads to weight regain. Here's what the research shows and how to plan for long-term success.

Most patients notice tirzepatide working within the first 1-2 weeks. Here's the full timeline from first dose to peak results, based on clinical data.

Semaglutide offers dual benefits for prediabetic patients: significant weight loss and meaningful improvements in blood sugar and insulin sensitivity.

Muscle loss is a concern with any significant weight loss — including GLP-1 therapy. Here's what the research shows and how to protect your muscle mass.

Compounded semaglutide is a lower-cost alternative to brand-name Wegovy. Here's what it is, whether it's safe, and what to look for in a physician-supervised program.